255 related articles for article (PubMed ID: 19191654)
1. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.
Veit O; Niedrig M; Chapuis-Taillard C; Cavassini M; Mossdorf E; Schmid P; Bae HG; Litzba N; Staub T; Hatz C; Furrer H;
Clin Infect Dis; 2009 Mar; 48(5):659-66. PubMed ID: 19191654
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali.
Sidibe M; Yactayo S; Kalle A; Sall AA; Sow S; Ndoutabe M; Perea W; Avokey F; Lewis RF; Veit O
Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):437-44. PubMed ID: 22627101
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
Sirikwin S; Likanonsakul S; Waradejwinyoo S; Pattamadilok S; Kumperasart S; Chaovavanich A; Manatsathit S; Malerczyk C; Wasi C
Vaccine; 2009 Jul; 27(32):4350-4. PubMed ID: 19487057
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.
Wallace MR; Brandt CJ; Earhart KC; Kuter BJ; Grosso AD; Lakkis H; Tasker SA
Clin Infect Dis; 2004 Oct; 39(8):1207-13. PubMed ID: 15486846
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients.
Pistone T; Verdière CH; Receveur MC; Ezzedine K; Lafon ME; Malvy D
Curr HIV Res; 2010 Sep; 8(6):461-6. PubMed ID: 20636276
[TBL] [Abstract][Full Text] [Related]
6. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
7. Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases.
Receveur MC; Thiébaut R; Vedy S; Malvy D; Mercié P; Bras ML
Clin Infect Dis; 2000 Sep; 31(3):E7-8. PubMed ID: 11017859
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
10. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.
Suzano CE; Amaral E; Sato HK; Papaiordanou PM;
Vaccine; 2006 Feb; 24(9):1421-6. PubMed ID: 16236402
[TBL] [Abstract][Full Text] [Related]
11. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
[TBL] [Abstract][Full Text] [Related]
12. CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.
Avelino-Silva VI; Miyaji KT; Hunt PW; Huang Y; Simoes M; Lima SB; Freire MS; Caiaffa-Filho HH; Hong MA; Costa DA; Dias JZ; Cerqueira NB; Nishiya AS; Sabino EC; Sartori AM; Kallas EG
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005219. PubMed ID: 27941965
[TBL] [Abstract][Full Text] [Related]
13. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection.
Kengsakul K; Sathirapongsasuti K; Punyagupta S
J Med Assoc Thai; 2002 Jan; 85(1):131-4. PubMed ID: 12075714
[TBL] [Abstract][Full Text] [Related]
14. Compromised B cell responses to influenza vaccination in HIV-infected individuals.
Malaspina A; Moir S; Orsega SM; Vasquez J; Miller NJ; Donoghue ET; Kottilil S; Gezmu M; Follmann D; Vodeiko GM; Levandowski RA; Mican JM; Fauci AS
J Infect Dis; 2005 May; 191(9):1442-50. PubMed ID: 15809902
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.
Colin de Verdiere N; Durier C; Samri A; Meiffredy V; Launay O; Matheron S; Mercier-Delarue S; Even S; Aboulker JP; Molina JM; Autran B; Simon F;
AIDS; 2018 Oct; 32(16):2291-2299. PubMed ID: 30096071
[TBL] [Abstract][Full Text] [Related]
16. Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland.
Myers C; Posfay-Barbe KM; Aebi C; Cheseaux JJ; Kind C; Rudin C; Nadal D; Siegrist CA; ;
Pediatr Infect Dis J; 2009 Nov; 28(11):996-1001. PubMed ID: 19820427
[TBL] [Abstract][Full Text] [Related]
17. Yellow fever vaccine for patients with HIV infection.
Barte H; Horvath TH; Rutherford GW
Cochrane Database Syst Rev; 2014 Jan; (1):CD010929. PubMed ID: 24453061
[TBL] [Abstract][Full Text] [Related]
18. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
19. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
20. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
Barrett AD; Teuwen DE
Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
